Margriet E. Gosselink

Margriet E. Gosselink

Auto-generated profile, based on publicly available information

Margriet E. Gosselink

Department of Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Kidney International
Verified
Journal Article
Open access
MGMargriet E. Gosselink
Margriet E. Gosselink
MBMarleen C. van Buren
Marleen C. van Buren
JKJudith Kooiman
Judith Kooiman
HGHenk Groen
Henk Groen
WGWessel Ganzevoort
Wessel Ganzevoort
ALA. Titia Lely
A. Titia Lely
Although numbers of pregnancy after kidney transplantation (KT) are rising, high risks of adverse pregnancy outcomes (APO) remain. Though important for pre-conception counselling and pregnancy monitoring, analyses of pregnancy outcomes after KT per pre-pregnancy estimated glomerular filtration rate-chronic kidney disease (eGFR-CKD)-categories have not been performed on a large scale before. To do this, we conducted a Dutch nationwide cohort study of consecutive singleton pregnancies over 20 weeks of gestation after KT. Outcomes were analyzed per pre-pregnancy eGFR-CKD category and a composite APO (cAPO) was established including birth weight under 2500 gram, preterm birth under 37 weeks, third trimester severe hypertension (systolic blood pressure over 160 and/or diastolic blood pressure over 110 mm Hg) and/or over 15% increase in serum creatinine during pregnancy. Risk factors for cAPO were analyzed in a multilevel model after multiple imputation of missing predictor values. In total, 288 pregnancies in 192 women were included. Total live birth was 93%, mean gestational age 35.6 weeks and mean birth weight 2383 gram. Independent risk factors for cAPO were pre-pregnancy eGFR, midterm percentage serum creatinine dip and midterm mean arterial pressure dip; odds ratio 0.98 (95% confidence interval 0.96-0.99), 0.95 (0.93-0.98) and 0.94 (0.90-0.98), respectively. The cAPO was a risk indicator for graft loss (hazard ratio 2.55, 1.09-5.96) but no significant risk factor on its own when considering pre-pregnancy eGFR (2.18, 0.92-5.13). This was the largest and most comprehensive study of pregnancy outcomes after KT, including pregnancies in women with poor kidney function, to facilitate individualized pre-pregnancy counselling based on pre-pregnancy graft function. Overall obstetric outcomes are good. The risk of adverse outcomes is mainly dependent on pre-pregnancy graft function and hemodynamic adaptation to pregnancy.

19 February 2024 in Kidney International
Verified
Journal Article
Open access
MGMargriet E. Gosselink
Margriet E. Gosselink
RSRozemarijn Snoek
Rozemarijn Snoek
ACAgne Cerkauskaite-Kerpauskiene
Agne Cerkauskaite-Kerpauskiene
SBSophie P.J. van Bakel
Sophie P.J. van Bakel
RVRenee Vollenberg
Renee Vollenberg
AEAlbertien M. van Eerde
Albertien M. van Eerde
Individualized pre-pregnancy counseling and antenatal care for women with chronic kidney disease (CKD) require disease-specific data. Here, we investigated pregnancy outcomes and long-term kidney function in women with COL4A3-5 related disease (Alport Syndrome, (AS)) in a large multicenter cohort. The ALPART-network (mAternaL and fetal PregnAncy outcomes of women with AlpoRT syndrome), an international collaboration of 17 centers, retrospectively investigated COL4A3-5 related disease pregnancies after the 20th week. Outcomes were stratified per inheritance pattern (X-Linked AS (XLAS)), Autosomal Dominant AS (ADAS), or Autosomal Recessive AS (ARAS)). The influence of pregnancy on estimated glomerular filtration rate (eGFR)-slope was assessed in 192 pregnancies encompassing 116 women (121 with XLAS, 47 with ADAS, and 12 with ARAS). Median eGFR pre-pregnancy was over 90ml/min/1.73m2. Neonatal outcomes were favorable: 100% live births, median gestational age 39.0 weeks and mean birth weight 3135 grams. Gestational hypertension occurred during 23% of pregnancies (reference: 'general' CKD G1-G2 pregnancies incidence is 4-20%) and preeclampsia in 20%. The mean eGFR declined after pregnancy but remained within normal range (over 90ml/min/1.73m2). Pregnancy did not significantly affect eGFR-slope (pre-pregnancy β=-1.030, post-pregnancy β=-1.349). ARAS-pregnancies demonstrated less favorable outcomes (early preterm birth incidence 3/11 (27%)). ARAS was a significant independent predictor for lower birth weight and shorter duration of pregnancy, next to the classic predictors (pre-pregnancy kidney function, proteinuria, and chronic hypertension) though missing proteinuria values and the small ARAS-sample hindered analysis. This is the largest study to date on AS and pregnancy with reassuring results for mild AS, though inheritance patterns could be considered in counseling next to classic risk factors. Thus, our findings support personalized reproductive care and highlight the importance of investigating kidney disease-specific pregnancy outcomes.

2 September 2024 in Kidney International Reports
Verified
Journal Article
Open access
MGMargriet E. Gosselink
Margriet E. Gosselink
RMRobin Mooren
Robin Mooren
RSRozemarijn Snoek
Rozemarijn Snoek
NCNeeltje M.T.H. Crombag
Neeltje M.T.H. Crombag
PVPaul Vos
Paul Vos
ALA. Titia Lely
A. Titia Lely
Family planning and reproductive care are essential but complex aspects of lifecycle management for individuals with autosomal dominant polycystic kidney disease (ADPKD), given the potential genetic transmission and pregnancy-related complications. In this qualitative study, we studied the experiences and perspectives of patients with ADPKD and clinicians to identify areas for potential improvement in reproductive lifecycle care. Focus group discussions (FGDs) were conducted in the Netherlands with patients with ADPKD, both men and women, who had children through varied reproductive choices; and clinicians, including (pediatric) nephrologists, obstetric gynecologists and geneticists. Thematic analysis, utilizing a grounded theory approach, was performed on verbatim transcriptions of recordings, followed by consensus discussions to finalize themes. Nine focus groups involving 31 participants (16 patients and 15 physicians) identified 6 key themes. These included the need for timely and comprehensive information dissemination from puberty on, understanding patient-specific decision-making factors, improving tailored psychosocial guidance and communication, the need for systematic efforts to take care of missed (minor) at-risk patients, addressing inequities in access to care, and improving multidisciplinary collaboration. This study represents the first qualitative study of patient and physician perspectives on reproductive lifecycle care for ADPKD. We present valuable insights into factors influencing patients’ reproductive decision-making, a comprehensive comparison between the perspectives of patients and clinicians on family planning and follow-up care of minors at risk for ADPKD, and recommendations for enhancing overall care quality. Incorporating these insights into clinical care could enhance patient-centered care and foster interdisciplinary collaborations to further improve the quality of reproductive health care services for individuals with ADPKD.

14 July 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
MGMargriet E. Gosselink
Margriet E. Gosselink
JSJolijn M.M. Sluijters
Jolijn M.M. Sluijters
RSRozemarijn Snoek
Rozemarijn Snoek
AEAlbertien M. van Eerde
Albertien M. van Eerde
KWKimberley E. Wever
Kimberley E. Wever
ALA. Titia Lely
A. Titia Lely
Key Points: Outcomes for women with mild CKD are reassuring: Pregnancy does not impair long-term kidney function in mild CKD. Women with advanced CKD should be informed on risks of losing prepregnancy kidney function in pregnancy. Animal studies support clinical findings in mild CKD and offer insights in the potential underlying mechanistics. Background: Pregnancy may accelerate kidney function decline in women with CKD, particularly in advanced stages. Some clinicians may therefore advise against pregnancy. Exact effect of pregnancy and subgroup risks (e.g., for patients with proteinuria or hypertension) are still uncertain. For patients with CKD who wish to conceive, establishing the effect of pregnancy and identifying those at risk for progression is crucial. Methods: We conducted a systematic review and meta-analysis in human and animal studies separately, synthesizing all available evidence on long-term kidney function after pregnancy in women with preexisting CKD. Primary outcome was standardized mean difference (SMD) in kidney function before versus after pregnancy. For clinical implications, we calculated mean GFR differences. Secondary outcomes were incidences of kidney failure/KRT after delivery and kidney function deterioration. Subanalyses stratified studies as mild versus advanced CKD if studies had ≤25% versus >25% of participants CKD stage 3–5 (unless cohorts defined otherwise) and chronic hypertension as 25% of participants having chronic hypertension. Results: We analyzed 36 human studies including 2945 patients, 4623 pregnancies, and 12 animal studies. Pregnancy had no effect on long-term kidney function in mild CKD cohorts (SMD, −0.22 [−0.56 to 0.13]) over a mean follow-up of 4.4 (SD 0.7) years. However, kidney function was significantly lower after pregnancy in advanced CKD cohorts (SMD, −0.55 [−0.80 to −0.30]), pooled eGFR decline −8.96 ml/min (−17.4 to −0.48), mean follow-up 2.6 years. Chronic hypertension affected overall SMD (β=−0.01 [−0.02 to −0.001], P = 0.03). Pooled kidney failure/KRT incidence was 9%, with a mean follow-up 6.5 of years. Pregnancy did not affect kidney function after delivery in animal nephropathy models. Conclusions: The results for patients with mild CKD are reassuring as pregnancy does not affect long-term kidney function. Animal studies support clinical findings in mild CKD and offer insights in the potential underlying mechanisms. Patients with advanced CKD should be informed on risking kidney function decline in pregnancy. Studies including eGFR-slopes prepregnancy and postpregnancy are scarce, limiting understanding of pregnancy's impact next to natural disease progression in advanced CKD. This highlights the need for future research including multiple eGFR measurements over time.